Literature DB >> 17911102

Keratocan and lumican regulate neutrophil infiltration and corneal clarity in lipopolysaccharide-induced keratitis by direct interaction with CXCL1.

Eric C Carlson1, Michelle Lin, Chia-Yang Liu, Winston W-Y Kao, Victor L Perez, Eric Pearlman.   

Abstract

Keratocan and lumican are keratan-sulfate proteoglycans (KSPG), which have a critical role in maintaining corneal clarity. To determine whether these KSPGs have a role in corneal inflammation, we examined Kera(-/-) and Lum(-/-) mice in a model of lipopolysaccharide (LPS)-induced keratitis in which wild-type mice develop increased corneal thickness and haze due to neutrophil infiltration to the corneal stroma. Corneal thickness increases caused by LPS mice were significantly lower in Kera(-/-) and Lum(-/-) than wild-type mice. Further, LPS-injected Lum(-/-) mice had elevated corneal haze levels compared with that of Kera(-/-) and wild-type. At 24 h post-injection, total enhanced green fluorescent protein-positive bone marrow-derived inflammatory cells in chimeric mice was significantly lower in Kera(-/-) mice and Lum(-/-) mice compared with wild-type mice. Neutrophil infiltration was inhibited in Kera(-/-) and Lum(-/-) mice at 6 and 24 h post-stimulation, with Lum(-/-) corneas having the most profound defect in neutrophil migration. Reconstitution of keratocan and lumican expression in corneas of Kera(-/-) and Lum(-/-) mice using adeno-keratocan and adeno-lumican viral vectors, respectively, resulted in normal neutrophil infiltration in response to LPS. Immunoprecipitation/Western blot analysis showed that lumican and keratocan core proteins bind the CXC chemokine KC during a corneal inflammatory response, indicating that corneal KSPGs mediate neutrophil recruitment to the cornea by regulating chemokine gradient formation. Together, these data support a significant role for lumican and keratocan in a corneal inflammatory response with respect to edema, corneal clarity, and cellular infiltration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17911102      PMCID: PMC3909483          DOI: 10.1074/jbc.M705823200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  In vivo gene delivery and visualization of corneal stromal cells using an adenoviral vector and keratocyte-specific promoter.

Authors:  Eric C Carlson; Chia-Yang Liu; Xiaoping Yang; Meredith Gregory; Bruce Ksander; Judith Drazba; Victor L Perez
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-07       Impact factor: 4.799

2.  CXCL1/KC and CXCL5/LIX are selectively produced by corneal fibroblasts and mediate neutrophil infiltration to the corneal stroma in LPS keratitis.

Authors:  Michelle Lin; Eric Carlson; Eugenia Diaconu; Eric Pearlman
Journal:  J Leukoc Biol       Date:  2006-11-16       Impact factor: 4.962

3.  Pseudomonas aeruginosa-induced inflammation in the rat extended-wear contact lens model.

Authors:  E A Szliter; Ronald P Barrett; Manal M Gabriel; Yunfan Zhang; Linda D Hazlett
Journal:  Eye Contact Lens       Date:  2006-01       Impact factor: 2.018

4.  Role of lumican in the corneal epithelium during wound healing.

Authors:  S Saika; A Shiraishi; C Y Liu; J L Funderburgh; C W Kao; R L Converse; W W Kao
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

5.  The role of CXC chemokine receptor 2 in Pseudomonas aeruginosa corneal infection.

Authors:  Shamila Khan; Nerida Cole; Emma B Hume; Linda Garthwaite; Timothy C R Conibear; David H Miles; Yulina Aliwaga; Mark B Krockenberger; Mark D P Willcox
Journal:  J Leukoc Biol       Date:  2006-10-06       Impact factor: 4.962

6.  Role of Cys41 in the N-terminal domain of lumican in ex vivo collagen fibrillogenesis by cultured corneal stromal cells.

Authors:  Eric C Carlson; Kazuhisa Mamiya; Chia-Yang Liu; Robert L Gendron; David E Birk; James L Funderburgh; Winston W-Y Kao
Journal:  Biochem J       Date:  2003-02-01       Impact factor: 3.857

7.  Keratocan-deficient mice display alterations in corneal structure.

Authors:  Chia-Yang Liu; David E Birk; John R Hassell; Bradley Kane; Winston W-Y Kao
Journal:  J Biol Chem       Date:  2003-03-28       Impact factor: 5.157

8.  Influence of calcium phosphate crystal assemblies on the proliferation and osteogenic gene expression of rat bone marrow stromal cells.

Authors:  Yang Liu; Paul R Cooper; Jake E Barralet; Richard M Shelton
Journal:  Biomaterials       Date:  2006-12-12       Impact factor: 12.479

9.  Altered KSPG expression by keratocytes following corneal injury.

Authors:  Eric C Carlson; I-Jong Wang; Chia-Yang Liu; Paul Brannan; Candace W C Kao; Winston W Y Kao
Journal:  Mol Vis       Date:  2003-11-21       Impact factor: 2.367

10.  A novel role of the lumican core protein in bacterial lipopolysaccharide-induced innate immune response.

Authors:  Feng Wu; Neeraj Vij; Luke Roberts; S Lopez-Briones; Sarah Joyce; Shukti Chakravarti
Journal:  J Biol Chem       Date:  2007-07-05       Impact factor: 5.157

View more
  42 in total

Review 1.  Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation.

Authors:  Kristin Moreth; Renato V Iozzo; Liliana Schaefer
Journal:  Cell Cycle       Date:  2012-06-01       Impact factor: 4.534

Review 2.  Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.

Authors:  Morten A Karsdal; Tina Manon-Jensen; Federica Genovese; Jacob H Kristensen; Mette J Nielsen; Jannie Marie B Sand; Niels-Ulrik B Hansen; Anne-Christine Bay-Jensen; Cecilie L Bager; Aleksander Krag; Andy Blanchard; Henrik Krarup; Diana J Leeming; Detlef Schuppan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-03-12       Impact factor: 4.052

Review 3.  Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.

Authors:  Morten A Karsdal; Mette J Nielsen; Jannie M Sand; Kim Henriksen; Federica Genovese; Anne-Christine Bay-Jensen; Victoria Smith; Joanne I Adamkewicz; Claus Christiansen; Diana J Leeming
Journal:  Assay Drug Dev Technol       Date:  2012-10-09       Impact factor: 1.738

Review 4.  The small leucine-rich repeat proteoglycans in tissue repair and atherosclerosis.

Authors:  A Hultgårdh-Nilsson; J Borén; S Chakravarti
Journal:  J Intern Med       Date:  2015-11       Impact factor: 8.989

5.  Bone marrow chimeras and c-fms conditional ablation (Mafia) mice reveal an essential role for resident myeloid cells in lipopolysaccharide/TLR4-induced corneal inflammation.

Authors:  Holly R Chinnery; Eric C Carlson; Yan Sun; Michelle Lin; Sandra H Burnett; Victor L Perez; Paul G McMenamin; Eric Pearlman
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

Review 6.  Small leucine-rich repeat proteoglycans in corneal inflammation and wound healing.

Authors:  Jihane Frikeche; George Maiti; Shukti Chakravarti
Journal:  Exp Eye Res       Date:  2016-08-26       Impact factor: 3.467

7.  Topical interleukin-1 receptor antagonist inhibits inflammatory cell infiltration into the cornea.

Authors:  W Michael Stapleton; Shyam S Chaurasia; Fabricio W Medeiros; Rajiv R Mohan; Sunilima Sinha; Steven E Wilson
Journal:  Exp Eye Res       Date:  2008-02-13       Impact factor: 3.467

8.  Cell therapy of congenital corneal diseases with umbilical mesenchymal stem cells: lumican null mice.

Authors:  Hongshan Liu; Jianhua Zhang; Chia-Yang Liu; I-Jong Wang; Martin Sieber; John Chang; James V Jester; Winston W Y Kao
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

Review 9.  Biological interplay between proteoglycans and their innate immune receptors in inflammation.

Authors:  Helena Frey; Nina Schroeder; Tina Manon-Jensen; Renato V Iozzo; Liliana Schaefer
Journal:  FEBS J       Date:  2013-02-21       Impact factor: 5.542

10.  The matricellular functions of small leucine-rich proteoglycans (SLRPs).

Authors:  Rosetta Merline; Roland M Schaefer; Liliana Schaefer
Journal:  J Cell Commun Signal       Date:  2009-10-02       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.